CODX

Co-Diagnostics Inc

0.2568

Nov 06 • 3:59 PM ET -0.0103 (-3.86%)

0.2699

Aftermarket • 7:23 PM ET +0.0131 (5.10%)

Healthcare Medical Devices USA Nano NASD

Nov 05, 3:03 PMS-3 registers 39.6M Astor resale shares, sending CODX down 24% in session

Peers: TRIB AIDX BMRA BJDX VNRX INBS ADGM NXL NUWE XAIR

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	2.44M
Enterprise Value	0.59M
Income	-47.06M
Sales	0.52M
Book/sh	2.61
Cash/sh	0.38
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	115
IPO	Jul 12, 2017

P/E	-
Forward P/E	-
PEG	-
P/S	4.69
P/B	0.10
P/C	0.67
P/FCF	-
EV/EBITDA	-
EV/Sales	1.13
Quick Ratio	1.52
Current Ratio	1.81
Debt/Eq	0.14
LT Debt/Eq	0.08
Option/Short	No / Yes

EPS (ttm)	-22.46
EPS next Y	-0.83
EPS next Q	-1.25
EPS this Y	91.21%
EPS next Y	73.23%
EPS next 5Y	80.05%
EPS past 3/5Y	-37.47% -
Sales past 3/5Y	-76.97% -64.54%
EPS Y/Y TTM	33.16%
Sales Y/Y TTM	-9.18%
EPS Q/Q	79.18%
Sales Q/Q	1.98%
Earnings	Nov 12 AMC
EPS/Sales Surpr.	- -

Insider Own	2.61%
Insider Trans	0.00%
Inst Own	7.31%
Inst Trans	7.63%
ROA	-149.25%
ROE	-174.77%
ROIC	-342.80%
Gross Margin	-170.74%
Oper. Margin	-5857.07%
Profit Margin	-9100.00%
SMA20	-54.78%
SMA50	-71.10%
SMA200	-87.97%
Trades

Shs Outstand	4.88M
Shs Float	-
Short Float	-
Short Ratio	1.73
Short Interest	0.66M
52W High	13.54 -98.10%
52W Low	0.26 -3.09%
Volatility	20.28% 16.41%
ATR (14)	0.08
RSI (14)	17.88
Beta	3.24
Rel Volume	1.40
Avg Volume	378.94K
Volume	528,883

Perf Week	-29.97%
Perf Month	-76.44%
Perf Quarter	-82.88%
Perf Half Y	-89.85%
Perf YTD	-94.92%
Perf Year	-97.83%
Perf 3Y	-99.30%
Perf 5Y	-99.90%
Perf 10Y	-
Recom	1.00
Target Price	4.00
Prev Close	0.27
Price	0.26
Change %	-3.86%

Nov-05-26 05:00PM	Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast (PR Newswire) -26.09%
09:00AM	Co-Diagnostics to Participate in Three Global Tuberculosis Events in November as CoSara Advances Toward Anticipated India Launch (PR Newswire)
Oct-29-26 09:15AM	Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast (PR Newswire) -10.49%
09:00AM	Co-Diagnostics' Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara's SARAGENE Test (PR Newswire)
Oct-27-26 07:45AM	Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India (PR Newswire) -14.32%
09:15AM	Loading…
Oct-20-26 09:15AM	Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum (PR Newswire)
Oct-15-26 09:15AM	Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection (PR Newswire) -6.46%
Oct-08-26 09:26AM	Co-Diagnostics Announces First Full Vector Smart Laboratory Installation for Native American Tribe (PR Newswire)
Oct-07-26 09:00AM	Co-Diagnostics Highlights Vector Smart Momentum Following New Federal Initiative on Vector-Borne Disease (PR Newswire)
Sep-23-26 09:00AM	Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week (PR Newswire)
Sep-21-26 09:00AM	Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation (PR Newswire) +6.80%
Sep-17-26 09:00AM	Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026 (PR Newswire)
Sep-16-26 08:45AM	Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola (PR Newswire) -17.47%
Sep-15-26 04:15PM	Co-Diagnostics to Hold Press Conference (PR Newswire)
Sep-10-26 09:00AM	Co-Diagnostics Completes New Vector Smart Laboratory Installations Amid Rising Dengue Activity in Florida (PR Newswire)
09:30AM	Loading…
Sep-01-26 09:30AM	Co-Diagnostics Expands Vector Smart Customer Reach with First International Installation in USAF Base (PR Newswire)
Aug-18-26 09:30AM	Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event (PR Newswire) -5.97%
Aug-14-26 01:03AM	Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FDA Submission Milestone and ... (GuruFocus.com) -6.04%
Aug-13-26 04:01PM	Co-Diagnostics Reports Second Quarter 2026 Financial Results (PR Newswire)
Aug-06-26 09:30AM	Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test (PR Newswire) -5.96%
Jul-30-26 09:00AM	Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast (PR Newswire)
Jul-28-26 08:00AM	Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies (PR Newswire) -30.88%
Jul-22-26 09:00AM	Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform (PR Newswire)
Jul-16-26 09:00AM	Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer (PR Newswire)
Jul-08-26 09:00AM	Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand (PR Newswire)
Jul-01-26 09:00AM	Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test (PR Newswire)
Jun-25-26 09:00AM	Co-Diagnostics Vector Smart Division Expands Footprint to 21 States (PR Newswire) -14.57%
Jun-18-26 09:05AM	Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line (PR Newswire)
Jun-11-26 09:00AM	Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx PCR Pro with Mexico Distributor Agreement (PR Newswire)
Jun-02-26 09:00AM	Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx PCR Point-of-Care Platform Capabilities (PR Newswire)
01:00PM	Loading…
May-26-26 01:00PM	CODX Stock Explodes Over 630% In Six Sessions Retail Traders Bet The Rally Isnt Over Yet (Stocktwits) +79.68%
09:00AM	Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara (PR Newswire)
May-19-26 10:54PM	Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire) +43.80% +21.32%
10:34AM	Co-Diagnostics Develops Ebola Assay Strategy Following WHO Emergency Alert (CODX) (InvestorsHub)
May-15-26 01:02AM	Co-Diagnostics Inc (CODX) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial ... (GuruFocus.com) -21.17%
May-14-26 04:01PM	Co-Diagnostics Reports First Quarter 2026 Financial Results (PR Newswire)
May-11-26 05:43AM	CoMira concludes lease agreement for plant in Sudair Industrial City, Saudi Arabia (Medical Device Network) -24.90%
May-08-26 09:00AM	Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City (PR Newswire) +31.09%
Apr-16-26 09:00AM	Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. (PR Newswire)
Apr-14-26 09:00AM	Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany (PR Newswire)
Apr-09-26 09:00AM	Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah (PR Newswire)
Apr-02-26 09:00AM	Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City (PR Newswire)
Mar-31-26 11:02PM	Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... (GuruFocus.com) +9.41% -12.90%
04:01PM	Co-Diagnostics Reports Full Year 2025 Financial Results (PR Newswire)
Mar-25-26 08:00AM	Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization (PR Newswire) -13.22%
Mar-20-26 03:30PM	Co-Diagnostics (CODX) Expands CoSara Distribution Territory Across South Asia (NewMediaWire)

Show Previous News

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

ChairmanMr. Dwight H. Egan

PresidentMr. Richard David Abbott

Executive VP of Finance & Accounting and Principal Financial & Accounting OfficerMr. Daniel Bohrer C.P.A.

Chief Operating OfficerMr. David Nielsen

Chief Technology OfficerMr. Christopher Thurston

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CODX

Co-Diagnostics Inc

Upgrade your Finviz experience